Dato-DXd binds TROP2 on cells, is internalized, and releases a DXd topoisomerase I inhibitor that causes DNA damage. Topoisomerase I is the intracellular enzyme targeted by the payload, not the cell-surface antigen; cells are killed only if TROP2-positive (or via bystander effect), not because they express topoisomerase I.